11 9 1075-83.Vujkovic-Cvijin I. Dunham R. M. Iwai S. Maher M. C. Albright R. G. Broadhurst M. J. Hernandez R. D. Lederman M. M. Huang Y. Somsouk M. Deeks S. G. Hunt P. W. Lynch S. V. and McCune J. M. 2013 Dysbiosis of the gut microbiota is associated withHIV disease progression and tryptophan catabolism.

Colon Rectum 38 12 1311-21.Sigthorsson G. Tibble J. Hayllar J. Menzies I. Macpherson A. Moots R. Scott D. Gumpel M. J. and Bjarnason I.

5193 193ra91.Budden K. F. Gellatly S. L. Wood D. L. Cooper M. A. Morrison M. Hugenholtz P. and Hansbro P. M. 2017 Emerging pathogenic links between microbiota and the gut-lung axis.

In J. Blutt S. E. de Jonge H. R. Estes M. K. and Donowitz M. 2016 Human EnteroidsColonoids and Intestinal Organoids Functionally Recapit- ulate Normal Intestinal Physiology and Pathophysiology.

420 2 239-250.Trapecar M. Goropevsek A. Gorenjak M. Gradisnik L. andCottet-Rousselle C. Ronot X. Leverve X. and Mayol J. F. 2011 Cytometric assessment of mitochondria using fluorescent probes.

291 8 3759-66.In J. G. Foulke-Abel J. Estes M. K. Zachos N. C. KovbasnjukO.

417 1 1-13.Mulrane L. Rexhepaj E. Penney S. Callanan J. J. and Gallagher W. M. 2008 Automated image analysis in histopathology a valuable tool in medical diagnostics.

JAMA 287 3 337-44.Wolfe M. M. Lichtenstein D. R. and Singh G. 1999 Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

2 9 2111-9.Le Ferrec E. Chesne C. Artusson P. Brayden D. Fabre G. Gires P. Guillou F. Rousset M. Rubas W. and Scarino M. L. 2001 In vitro models of the intestinal barrier.

340 24 1888-99.Ehsanullah R. S. Page M. C. Tildesley G. and Wood J. R. 1988 Prevention of gastroduodenal damage induced by non-steroidal anti- inflammatory drugs controlled trial of ranitidine.

